A personalised vaccine against melanoma can more than double the survival
rate for patients with the advanced form of this skin cancer. Doctors at
Jefferson Medical College in Philadelphia create customised vaccines from
patients鈥� own cancer cells by inactivating them and altering their surface
proteins with dinitrophenol. Five-year survival rates in 214 patients with
advanced disease increased from around 20 per cent to 50 per cent and a
randomised phase III trial of 400 patients across the US is planned.
More from New 女生小视频
Explore the latest news, articles and features
Health
Personalised cancer vaccine expected to be approved next year
News
Technology
Brazil presidential election dogged by alleged bias by Meta AI tools
News
Health
Body temperature may drive the higher risk of autoimmune conditions in women
News
Comment
Emily St. John Mandel: ‘I don’t want to write something relentlessly bleak’
Culture
Popular articles
Trending New 女生小视频 articles